- AI, controlled by DeepMind, is going to change the way we discover new drugs, says CEO Demis Hassabis.
- Isomorphic Labs uses AI to speed up drug discovery. Instead of taking years, they can do it in just a few months.
- Collaborations with big drug companies prove that AI can make a big difference in healthcare.
At a big tech event in Barcelona, Demis Hassabis, the boss of Google DeepMind, said that he thinks AI will start making drugs in hospitals in the next few years. DeepMind is well known for its advanced AI research. Their Alphafold system can predict protein structures, and it is set to change the way we discover new drugs.
AI could change the way new medicines are created
Hassabis explained how AI could greatly influence finding new drugs. He emphasized the importance of understanding protein structures in this process. Scientists can use DeepMind’s Alphafold system to figure out the detailed shapes of proteins. This makes it easier to create drugs that can attach to specific parts of these proteins. This accuracy could help reduce bad reactions and improve the way we find new drugs.
Isomorphic labs: Leading the way in using AI to discover new drugs
Hassabis led the creation of Isomorphic Labs, a company in London that makes medicine, under Alphabet, Google’s parent company, to make his idea come true. Isomorphic Labs uses AI to create new chemicals that only attach to certain proteins, so they don’t hurt healthy tissues. With Isomorphic’s new way of doing things, the difficult process of finding new drugs, which usually takes ten years, could be much faster, maybe just a few months.
Industry approval and partnerships
Isomorphic Labs has become very successful and has partnered with big pharmaceutical companies like Eli Lilly and Novartis. These partnerships are worth up to $3 billion and show that the pharmaceutical industry believes AI can make finding new drugs faster. Working together is an important step in making new medicines quickly to fight common diseases.
Health tech innovation: AI’s role in accelerating medical breakthroughs
Isomorphic Labs is making big progress in using AI to discover new drugs, which is part of a bigger trend in health technology. Companies such as Nuclera are using AI to make medical research and development faster and more efficient. Nuclera’s platform will make it much quicker to find important proteins for making drugs. It will take only a few days instead of months or years. These new ideas are very promising in helping to solve important medical problems and making healthcare better.
Using AI to quickly improve how we find and create new drugs
As AI becomes more common in healthcare and pharmaceuticals, it has a lot of potential to change the way we discover new drugs. New technology and scientific advancements are coming together to create a new time where we might be able to find cures for diseases that used to be unbeatable, thanks to AI helping to design new drugs. With the help of leaders like Demis Hassabis and companies like Isomorphic Labs, we are getting closer to finding new medicines quickly to fight important global health problems.
Demis Hassabis has shown how AI could change the way we discover new medicines. Cutting-edge AI platforms like Alphafold and Isomorphic Labs are changing how pharmaceutical research is done. There’s a big change coming soon. As big companies work with new, creative startups, they can develop new drugs quickly to help with important medical problems. The start of AI-powered drug design will speed up new medical discoveries and change what we thought was possible in fighting diseases.
Warning: This information is not advice for trading.
